Zobrazeno 1 - 10
of 129
pro vyhledávání: '"H, Hedin"'
Autor:
Samira Salihovic, Niklas Nyström, Charlotte Bache-Wiig Mathisen, Robert Kruse, Christine Olbjørn, Svend Andersen, Alexandra J. Noble, Maria Dorn-Rasmussen, Igor Bazov, Gøri Perminow, Randi Opheim, Trond Espen Detlie, Gert Huppertz-Hauss, Charlotte R. H. Hedin, Marie Carlson, Lena Öhman, Maria K. Magnusson, Åsa V. Keita, Johan D. Söderholm, Mauro D’Amato, Matej Orešič, Vibeke Wewer, Jack Satsangi, Carl Mårten Lindqvist, Johan Burisch, Holm H. Uhlig, Dirk Repsilber, Tuulia Hyötyläinen, Marte Lie Høivik, Jonas Halfvarson
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Improved biomarkers are needed for pediatric inflammatory bowel disease. Here we identify a diagnostic lipidomic signature for pediatric inflammatory bowel disease by analyzing blood samples from a discovery cohort of incident treatment-naï
Externí odkaz:
https://doaj.org/article/8a477108fc6e4a34a2cccb17d607374e
Publikováno v:
Nature Reviews Gastroenterology & Hepatology. 19:493-507
Autor:
S Salihovic, N Nyström, C Bache-Wiig Mathisen, S Andersen, C Olbjørn, G Perminow, R Opheim, T E Detlie, G Huppertz-Hauss, I Bazov, R Kruse, C M Lindqvist, C R H Hedin, M Carlson, L Öhman, M Magnusson, Å V Keita, J D Söderholm, M D’Amato, M Orešič, D Repsilber, T Hyötyläinen, M L Hoivik, J Halfvarson
Publikováno v:
Journal of Crohn's and Colitis. 17:i76-i77
Background Improved diagnostic biomarkers are an unmet clinical need for paediatric inflammatory bowel disease (IBD). We therefore aimed to identify a diagnostic lipidomic signature of IBD in blood. Methods We performed a non-targeted liquid chromato
Autor:
Triana Lobaton, Konstantinos Karmiris, Rimma Goldberg, Pierre Ellul, John P. Burke, Carsten Schmidt, Johan Burisch, Tim Raine, Uri Kopylov, Garret Cullen, Konstantinos Katsanos, Stefan D. Holubar, Charlotte R H Hedin, Raja Atreya, Bram Verstockt
Publikováno v:
Journal of Crohn's and Colitis. 15:1605-1620
Inflammatory bowel disease is a chronic disease with variable degrees of extent, severity, and activity. A proportion of patients will have disease that is refractory to licensed therapies, resulting in significant impairment in quality of life. The
Autor:
Joel, Thunberg, Olle, Björkqvist, Charlotte R H, Hedin, Anders, Forss, Charlotte, Söderman, Daniel, Bergemalm, Ola, Olén, Henrik, Hjortswang, Hans, Strid, Jonas F, Ludvigsson, Carl, Eriksson, Jonas, Halfvarson
Publikováno v:
United European gastroenterology journal. 10(7)
Background Real-world data on clinical outcomes of ustekinumab in ulcerative colitis are lacking. Objective To assess short- and long-term clinical outcomes of ustekinumab in ulcerative colitis. Methods Adult ulcerative colitis patients without previ
Autor:
Ann-Sofie Backman, Katja A Kulmala, Sara Andersson, Charlotte R H Hedin, Michael Eberhardson, Jan Björk, Francesca Bresso
Publikováno v:
Scandinavian Journal of Gastroenterology. 55:1185-1192
Effects of nutritional intake on inflammatory bowel disease (IBD) flare resolution are unknown. We hypothesised that nutritional factors during hospitalisation for acute severe IBD are associated with risk of subsequent relapse. We also studied risk
Autor:
Lars E. Borm, Alejandro Mossi Albiach, Camiel C. A. Mannens, Jokubas Janusauskas, Ceren Özgün, David Fernández-García, Rebecca Hodge, Francisca Castillo, Charlotte R. H. Hedin, Eduardo J. Villablanca, Per Uhlén, Ed S. Lein, Simone Codeluppi, Sten Linnarsson
Publikováno v:
Nature biotechnology.
Methods to spatially profile the transcriptome are dominated by a trade-off between resolution and throughput. Here we develop a method named Enhanced ELectric Fluorescence in situ Hybridization (EEL FISH) that can rapidly process large tissue sample
Autor:
Michael, Eberhardson, Pär, Myrelid, Jonas K, Söderling, Anders, Ekbom, Åsa H, Everhov, Charlotte R H, Hedin, Martin, Neovius, Jonas F, Ludvigsson, Caroline, Nordenvall
Publikováno v:
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland. 24(4)
Aim Surgery is an important therapeutic option for Crohns disease. The need for first bowel surgery seems to have decreased with the introduction of tumour necrosis factor inhibitors (TNFi; adalimumab or infliximab). However, the impact of TNFi on th
Autor:
Charlotte R H Hedin, Bram Verstockt, Marla Dubinsky, Tine Jess, Iago Rodríguez-Lago, Joana Torres, Claudio Fiocchi, Michael Scharl, Kenneth Croitoru, Jean-Frederic Colombel, Jonas Halfvarson
Publikováno v:
Torres, J, Halfvarson, J, Rodríguez-Lago, I, Hedin, C R H, Jess, T, Dubinsky, M, Croitoru, K, Colombel, J-F & Scientific Workshop Steering Committee 2021, ' Results of the Seventh Scientific Workshop of ECCO : Precision medicine in IBD-prediction and prevention of inflammatory bowel disease ', Journal of Crohn's & colitis, vol. 15, no. 9, pp. 1443-1454 . https://doi.org/10.1093/ecco-jcc/jjab048
Inflammatory bowel disease [IBD] is a complex chronic disorder with no clear aetiology and no known cure. Despite recent advances in overall disease management and improved therapeutics, patients with IBD still experience a substantial burden. Furthe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfa48a6e40f17238fd468f30c2ed733e
https://vbn.aau.dk/da/publications/4524a69d-7a5d-42a8-8664-9b3fcd67a239
https://vbn.aau.dk/da/publications/4524a69d-7a5d-42a8-8664-9b3fcd67a239
Publikováno v:
Journal of Crohn's & Colitis
Current practice in IBD is to classify patients based on clinical signs and symptoms and provide treatments accordingly. However, the response of IBD patients to available treatments is highly variable, highlighting clinically significant heterogenei